HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Makoto Sunagawa Selected Research

SM-216601

10/2005In vitro and in vivo antibacterial activities of SM-216601, a new broad-spectrum parenteral carbapenem.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Makoto Sunagawa Research Topics

Disease

4Infections
02/2013 - 08/2002
3Neoplasms (Cancer)
03/2010 - 06/2007
3Coronary Disease (Coronary Heart Disease)
10/2009 - 06/2004
2Atherosclerosis
10/2009 - 06/2004
2Insulin Resistance
06/2006 - 06/2004
2Bacterial Infections (Bacterial Infection)
10/2005 - 08/2003
1Out-of-Hospital Cardiac Arrest
12/2021
1Community-Acquired Infections
02/2013
1Hyperplasia
10/2009
1Xanthomatosis (Xanthoma)
10/2009
1Hypercholesterolemia
10/2009
1Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
10/2009
1Atrophy
07/2007
1Abscess
08/2003

Drug/Important Bio-Agent (IBA)

2Carbapenems (Carbapenem Antibiotics)IBA
02/2013 - 08/2003
2Ampicillin (Omnipen)FDA LinkGeneric
02/2013 - 08/2003
2Cell Wall SkeletonIBA
03/2010 - 06/2007
2oxidized low density lipoproteinIBA
10/2009 - 06/2004
2Pharmaceutical PreparationsIBA
06/2007 - 08/2002
2Lipoproteins (Lipoprotein)IBA
06/2006 - 06/2004
2Insulin (Novolin)FDA Link
06/2006 - 06/2004
1tebipenemIBA
02/2013
1Ciprofloxacin (Cipro)FDA LinkGeneric
02/2013
1Methicillin (Metin)FDA Link
02/2013
1Penicillins (Penicillin)FDA Link
02/2013
1SolutionsIBA
03/2010
1Hydrochloric Acid (Hydrogen Chloride)FDA Link
03/2010
1Arabinose (L-Arabinose)IBA
03/2010
1TolueneIBA
03/2010
1LipidsIBA
10/2009
1LDL CholesterolIBA
10/2009
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2009
1Cord FactorsIBA
07/2007
1Biological ProductsIBA
07/2007
1MicellesIBA
07/2007
1C-Reactive ProteinIBA
06/2006
1AdipokinesIBA
06/2006
1Uric Acid (Urate)IBA
06/2006
1SM-216601IBA
10/2005
1Apolipoprotein A-I (Apolipoprotein A1)IBA
06/2004
1Apolipoproteins B (ApoB)IBA
06/2004
1HDL CholesterolIBA
06/2004
1Glucose (Dextrose)FDA LinkGeneric
06/2004
1Triglycerides (Triacylglycerol)IBA
06/2004
1Linezolid (Zyvox)FDA Link
08/2003
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2003
16- (1- hydroxyethyl)- 4- methyl- 3- ((4- (2- methyl- 1,2,3,6- tetrahydropyridin- 4- yl)- 1,3- thiazol- 2- yl)thio)- 7- oxo- 1- azabicyclo(3.2.0)hept- 2- ene- 2- carboxylic acidIBA
08/2003
1VancomycinFDA LinkGeneric
08/2003
1ImipenemFDA Link
08/2003
1Anti-Infective Agents (Microbicides)IBA
08/2002

Therapy/Procedure

2Immunotherapy
05/2009 - 06/2007
1Cardiopulmonary Resuscitation (CPR)
12/2021
1Defibrillators (Defibrillator)
12/2021
1Intravenous Administration
02/2013
1Therapeutics
10/2009